Summary

225.25 -3.01(-1.32%)07/01/2024
Analog Devices Inc. (ADI)

Key Facts


1 Day1 Week1 Month3 Months6 Months1 Year5 YearsAll Time
-1.30-1.34-2.9014.5616.3616.46112.1048,502.87


Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1


Trading Data
Close225.25
Open226.70
High226.95
Low223.96
Volume1,709,648
Change-2.97
Change %-1.30
Avg Volume (20 Days)1,928,580
Volume/Avg Volume (20 Days) Ratio0.89
52 Week Range154.99 - 241.88
Price vs 52 Week High-6.88%
Price vs 52 Week Low45.33%
Range-0.64
Gap Up/Down-5.37
Fundamentals
Market Capitalization (Mln)113,266
EBIDTA5,681,083,904
PE Ratio37.0644
PEG Ratio3.6138
WallStreet Target Price213.29
Book Value71.6830
Earnings Per Share5.5900
EPS Estimate Current Quarter1.7000
EPS Estimate Next Quarter0.0000
EPS Estimate Current Year5.9500
EPS Estimate Next Year7.5700
Diluted EPS (TTM)5.5900
Revenues
Profit Marging0.2434
Operating Marging (TTM)0.2396
Return on asset (TTM)0.0437
Return on equity (TTM)0.0781
Revenue TTM11,568,613,376
Revenue per share TTM23.1650
Quarterly Revenue Growth (YOY)-0.2270
Quarterly Earnings Growth (YOY)-0.5050
Gross Profit (TTM)7,877,218,000
Dividends
Dividend Share3.5000
Dividend Yield0.0178
Valuations
Trailing PE37.0644
Forward PE31.4465
Price Sales (TTM)0.0000
Price Book (MRQ)2.6822
Revenue Enterprise Value 8.7336
EBITDA Enterprise Value18.1714
Shares
Shares Outstanding495,908,000
Shares Float493,483,159
Shares Short0
Shares Short (Prior Month)0
Shares Ratio0.00
Short Outstanding (%)0.00
Short Float (%)0.02
Insider (%)0.24
Institutions (%)92.38


06/24 07:00 EST - businesswire.com
Adicet Bio Announces FDA Clearance of IND Application for ADI-270 in Renal Cell Carcinoma
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application to evaluate ADI-270, an armored allogeneic “off-the-shelf” gamma delta chimeric antigen receptor (CAR) T cell therapy candidate targeting CD70.
06/21 12:31 EST - zacks.com
Why Is Analog Devices (ADI) Down 2.2% Since Last Earnings Report?
Analog Devices (ADI) reported earnings 30 days ago. What's next for the stock?
06/06 09:58 EST - seekingalpha.com
Buy Alert: 2 Top Dividend Stocks To Buy In June
Selling in May and going away doesn't work.
06/04 19:00 EST - prnewswire.com
LG Energy Solution Teams up with Analog Devices, Inc. to Gain Competitive Edge in Battery Management Total Solution
LG Energy Solution signs MoU with Analog Devices, Inc. (ADI), a global semiconductor leader with Innovative Intelligence at the Edge technologies in the field of battery management. The companies are working towards co-development of a technology that will enable precise measurement of battery cells' internal temperature.
05/29 17:54 EST - seekingalpha.com
Analog Devices, Inc. (ADI) Bernstein 40th Annual Strategic Decisions Conference (Transcript)
Analog Devices, Inc. (NASDAQ:ADI ) Bernstein 40th Annual Strategic Decisions Conference May 29, 2024 10:00 AM ET Company Participants Michael Lucarelli - VP, IR & FP&A Richard Puccio - Executive VP & CFO Conference Call Participants Stacy Rasgon - Bernstein Stacy Rasgon I guess, we'll get started. Good morning, everyone.
05/24 11:00 EST - investorplace.com
3 Tech Stocks Flying Under the Radar but Ready to Soar 50% Higher
Certain technology companies get all the attention and generate all the media headlines. This fact leaves many companies lurking in the shadows and off the radar screens of investors.
05/23 16:00 EST - prnewswire.com
Analog Devices to Participate in the Bernstein Strategic Decisions Conference
WILMINGTON, Mass. , May 23, 2024 /PRNewswire/ -- Analog Devices, Inc. (Nasdaq: ADI) today announced that the Company's Executive Vice President & Chief Financial Officer, Richard Puccio, will discuss business topics and trends at the Bernstein 40th Annual Strategic Decisions Conference taking place at the New York Hilton Midtown Hotel, located in New York, New York, on Wednesday, May 29, 2024, at 10:00 a.m.
05/23 06:15 EST - marketbeat.com
Analog Devices Extends Rally: Signals Start to Cyclical Recovery
Analog Devices NASDAQ: ADI share prices are surging because a trough is in place, and the outlook is robust. The FQ2 results and guidance for FQ3 aren't robust but show markets stronger than expected, and AI supports the pivot back to growth.
05/22 12:46 EST - seekingalpha.com
Analog Devices, Inc. (ADI) Q2 2024 Earnings Call Transcript
Analog Devices, Inc. (NASDAQ:ADI ) Q2 2024 Results Conference Call May 22, 2024 10:00 AM ET Company Participants Michael Lucarelli - VP, IR and FP&A Vincent Roche - CEO & Chairman Richard Puccio - CFO Conference Call Participants Tore Svanberg - Stifel Stacy Rasgon - Bernstein Research Toshiya Hari - Goldman Sachs Vivek Arya - Bank of America Securities Christopher Danley - Citigroup Ross Seymore - Deutsche Bank Mark Lipacis - Evercore ISI Harlan Sur - JPMorgan Joseph Moore - Morgan Stanley Operator Good morning, and welcome to the Analog Devices' Second Quarter Fiscal Year 2024 Earnings Conference Call, which is being audio webcast via telephone and over the web. I'd like to now introduce your host for today's call Mr.
05/22 12:30 EST - youtube.com
Analog Devices CEO Vincent Roche on Q2 earnings
Analog Devices CEO Vincent Roche joins CNBC's 'Money Movers' to discuss the company's earnings report, implementing AI, and more.
05/22 12:21 EST - zacks.com
Analog Devices (ADI) Q2 Earnings & Revenues Beat, Fall Y/Y
Analog Devices' (ADI) results for the fiscal second quarter are hurt by weakness across the industrial, communications, automotive and consumer markets.
05/22 12:17 EST - youtube.com
Analog Devices (ADI) on Pace for Record Close
Analog Devices (ADI) is on pace for a record close. Renita Young discusses this as Analog Devices' 2Q adjusted EPS came in at $1.40 versus an estimated $1.26 and revenue came in at $2.16B versus an estimated $2.10B.
05/22 12:05 EST - investopedia.com
Analog Devices Sees a Business Recovery Ahead, and Stock Hits a Record High
Analog Devices (ADI) shares soared to a record high Wednesday after the semiconductor maker posted better-than-expected results and guidance as inventory backlogs eased.
05/22 10:31 EST - zacks.com
Analog Devices (ADI) Reports Q2 Earnings: What Key Metrics Have to Say
The headline numbers for Analog Devices (ADI) give insight into how the company performed in the quarter ended April 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
05/22 07:29 EST - barrons.com
Analog Devices Stock Jumps. A Strong Outlook Is a Reason Why.
Analog Devices expects fiscal third-quarter revenue of $2.27 billion, plus or minus $100 million. The forecast tops analysts' estimates.
05/22 07:09 EST - investors.com
Chipmaker Analog Devices Posts Beat-And-Raise Q2 Earnings Report
Chipmaker Analog Devices beat Wall Street's targets for its fiscal Q2 and guided higher than views for the current period.
05/22 07:05 EST - reuters.com
Analog Devices forecasts quarterly revenue above estimates
Analog Devices forecast third-quarter revenue above Wall Street expectations on Wednesday, helped by a rise in demand for its automotive and industrial chips after a prolonged slump.
05/22 07:00 EST - prnewswire.com
Analog Devices Reports Fiscal Second Quarter 2024 Financial Results
Revenue of $2.16 billion, above the midpoint of our outlook Operating cash flow of $4.3 billion and free cash flow of $3.1 billion on a trailing twelve-month basis Returned over $675 million to shareholders through dividends and repurchases in the second quarter WILMINGTON, Mass. , May 22, 2024 /PRNewswire/ -- Analog Devices, Inc. (Nasdaq: ADI), a global semiconductor leader, today announced financial results for its fiscal second quarter 2024, which ended May 4, 2024.
05/21 13:00 EST - investorplace.com
Top Picks: Why TM, ADI, and COST Are Standout Stocks for Next Decade
When considering the best stocks for the next decade of investing, it's important to remember one thing: no one has a crystal ball. While past performance can help characterize a company up until its present-day trading price, nothing or no one can perfectly predict what a company's future performance will be.